Literature DB >> 30107610

Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis.

Christian Núñez1,2, Christian Stephan-Otto1,2,3, Judith Usall1,2,3, Miquel Bioque3,4,5, Antonio Lobo6, Ana González-Pinto7, Laura Pina-Camacho3,8, Eduard Vieta3,9, Josefina Castro-Fornieles3,5,10,11, Roberto Rodriguez-Jimenez12, Anna Butjosa1,2, Joost Janssen3,8,13, Bibiana Cabrera3,4, Mara Parellada3,8, Miquel Bernardo3,4,5,14.   

Abstract

Although there is recent evidence that cells from the peripheral immune system can gain access to the central nervous system in certain conditions such as multiple sclerosis, their role has not been assessed in psychosis. Here, we aimed to explore whether blood cell count was associated with brain volume and/or clinical symptomatology. A total of 218 participants (137 first-episode psychosis patients [FEP] and 81 healthy controls [HC]) were included in the study. For each participant, a T1 structural image was acquired, from which brain tissue volumes were calculated. We found that, in FEP, neutrophil count was associated with reduced gray matter (GM) volume (β = -0.117, P < .001) and increased cerebrospinal fluid volume (β = 0.191, P = .007). No associations were observed in HC. GM reduction was generalized but more prominent in certain regions, notably the thalamus, the anterior insula, and the left Heschl's gyrus, among many others. Neutrophil count was also associated with the total PANSS score (β = 0.173, P = .038), including those items assessing hallucinations (β = 0.182, P = .028) and avolition (β = 0.197, P = .018). Several confounders, such as antipsychotic medication, body mass index, and smoking, were controlled for. Overall, the present study may represent the first indirect evidence of brain tissue loss associated with neutrophils in psychosis, and lends support to the hypothesis of a dysregulated immune system. Higher neutrophil count was also associated with more severe clinical symptomatology, which renders it a promising indicator of schizophrenia severity and could even give rise to new therapies.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  avolition; hallucinations; leucocytes; neuroimmunology; structural neuroimaging

Year:  2019        PMID: 30107610      PMCID: PMC6581126          DOI: 10.1093/schbul/sby113

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  65 in total

1.  Red blood cell clearance in inflammation.

Authors:  Marleen Straat; Robin van Bruggen; Dirk de Korte; Nicole P Juffermans
Journal:  Transfus Med Hemother       Date:  2012-09-06       Impact factor: 3.747

Review 2.  Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?

Authors:  Amanda L Jones; Bryan J Mowry; Michael P Pender; Judith M Greer
Journal:  Immunol Cell Biol       Date:  2005-02       Impact factor: 5.126

Review 3.  Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.

Authors:  Vanessa H Brait; Thiruma V Arumugam; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-01       Impact factor: 6.200

Review 4.  Dealing with Danger in the CNS: The Response of the Immune System to Injury.

Authors:  Sachin P Gadani; James T Walsh; John R Lukens; Jonathan Kipnis
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

5.  Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model.

Authors:  Sung Hoon Baik; Moon-Yong Cha; Young-Min Hyun; Hansang Cho; Bashar Hamza; Dong Kyu Kim; Sun-Ho Han; Heesun Choi; Kyung Ho Kim; Minho Moon; Jeewoo Lee; Minsoo Kim; Daniel Irimia; Inhee Mook-Jung
Journal:  Neurobiol Aging       Date:  2014-01-08       Impact factor: 4.673

6.  Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.

Authors:  P Esposito; D Gheorghe; K Kandere; X Pang; R Connolly; S Jacobson; T C Theoharides
Journal:  Brain Res       Date:  2001-01-05       Impact factor: 3.252

7.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus.

Authors:  Nicholas H Varvel; Jonas J Neher; Andrea Bosch; Wenyi Wang; Richard M Ransohoff; Richard J Miller; Raymond Dingledine
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

8.  Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.

Authors:  Elena Zenaro; Enrica Pietronigro; Vittorina Della Bianca; Gennj Piacentino; Laura Marongiu; Simona Budui; Ermanna Turano; Barbara Rossi; Stefano Angiari; Silvia Dusi; Alessio Montresor; Tommaso Carlucci; Sara Nanì; Gabriele Tosadori; Lucia Calciano; Daniele Catalucci; Giorgio Berton; Bruno Bonetti; Gabriela Constantin
Journal:  Nat Med       Date:  2015-07-27       Impact factor: 53.440

9.  The role of the choroid plexus in neutrophil invasion after traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Nathalie Strazielle; Brian J Zink; Jean-François Ghersi-Egea; Adam Chodobski
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-27       Impact factor: 6.200

10.  Long-term Risk of Dementia in Persons With Schizophrenia: A Danish Population-Based Cohort Study.

Authors:  Anette Riisgaard Ribe; Thomas Munk Laursen; Morten Charles; Wayne Katon; Morten Fenger-Grøn; Dimitry Davydow; Lydia Chwastiak; Joseph M Cerimele; Mogens Vestergaard
Journal:  JAMA Psychiatry       Date:  2015-11       Impact factor: 21.596

View more
  12 in total

1.  Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness.

Authors:  Daniel Bergé; Anna Mané; Tyler A Lesh; Miquel Bioque; Fe Barcones; Ana Maria Gonzalez-Pinto; Mara Parellada; Eduard Vieta; Josefina Castro-Fornieles; Roberto Rodriguez-Jimenez; Maria Paz García-Portilla; Judith Usall; Cameron S Carter; Bibiana Cabrera; Miguel Bernardo; Joost Janssen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 2.  The impact of inflammation on neurocognition and risk for psychosis: a critical review.

Authors:  Sophia Kogan; Luz H Ospina; Vijay A Mittal; David Kimhy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-10-16       Impact factor: 5.270

3.  DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.

Authors:  Eilis Hannon; Emma L Dempster; Georgina Mansell; Joe Burrage; Nick Bass; Marc M Bohlken; Aiden Corvin; Charles J Curtis; David Dempster; Marta Di Forti; Timothy G Dinan; Gary Donohoe; Fiona Gaughran; Michael Gill; Amy Gillespie; Cerisse Gunasinghe; Hilleke E Hulshoff; Christina M Hultman; Viktoria Johansson; René S Kahn; Jaakko Kaprio; Gunter Kenis; Kaarina Kowalec; James MacCabe; Colm McDonald; Andrew McQuillin; Derek W Morris; Kieran C Murphy; Colette J Mustard; Igor Nenadic; Michael C O'Donovan; Diego Quattrone; Alexander L Richards; Bart Pf Rutten; David St Clair; Sebastian Therman; Timothea Toulopoulou; Jim Van Os; John L Waddington; Patrick Sullivan; Evangelos Vassos; Gerome Breen; David Andrew Collier; Robin M Murray; Leonard S Schalkwyk; Jonathan Mill
Journal:  Elife       Date:  2021-02-26       Impact factor: 8.140

Review 4.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

5.  Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function.

Authors:  Chunyan Luo; XueNan Pi; Na Hu; Xiao Wang; Yuan Xiao; Siyi Li; John A Sweeney; Jeffrey R Bishop; Qiyong Gong; Dan Xie; Su Lui
Journal:  Mol Psychiatry       Date:  2021-09-29       Impact factor: 15.992

Review 6.  Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia.

Authors:  Amira Bryll; Justyna Skrzypek; Wirginia Krzyściak; Maja Szelągowska; Natalia Śmierciak; Tamas Kozicz; Tadeusz Popiela
Journal:  Biomolecules       Date:  2020-03-02

7.  Review of Standard Laboratory Blood Parameters in Patients with Schizophrenia and Bipolar Disorder.

Authors:  Amra Memic-Serdarevic; Lejla Burnazovic-Ristic; Gorana Sulejmanpasic; Amir Tahirovic; Amina Valjevac; Edina Lazovic
Journal:  Med Arch       Date:  2020-10

8.  Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study.

Authors:  Xia Zhou; Xiaolan Wang; Rui Li; Jun Yan; Ying Xiao; Weiguang Li; Hong Shen
Journal:  Front Psychiatry       Date:  2020-10-30       Impact factor: 4.157

9.  Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.

Authors:  Johann Steiner; Thomas Frodl; Kolja Schiltz; Henrik Dobrowolny; Roland Jacobs; Brisa S Fernandes; Paul C Guest; Gabriela Meyer-Lotz; Katrin Borucki; Sabine Bahn; Bernhard Bogerts; Peter Falkai; Hans-Gert Bernstein
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

10.  Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses.

Authors:  Saskia Räuber; Michael Heming; Jonathan Repple; Tillmann Ruland; Rebecca Kuelby; Andreas Schulte-Mecklenbeck; Catharina C Gross; Volker Arolt; Bernhard Baune; Tim Hahn; Udo Dannlowski; Sven G Meuth; Nico Melzer; Heinz Wiendl; Gerd Meyer Zu Hörste
Journal:  Mol Psychiatry       Date:  2021-08-06       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.